Technical Analysis for CGIX - Cancer Genetics, Inc.

Grade Last Price % Change Price Change
grade F 0.26 2.20% 0.01
CGIX closed up 2.2 percent on Monday, March 18, 2019, on 84 percent of normal volume.

Earnings due: Apr 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CGIX trend table...

Date Alert Name Type % Chg
Mar 18 Crossed Above 20 DMA Bullish 0.00%
Mar 18 Bollinger Band Squeeze Range Contraction 0.00%
Mar 18 Doji - Bearish? Reversal 0.00%
Mar 15 20 DMA Resistance Bearish 2.20%
Mar 15 Bollinger Band Squeeze Range Contraction 2.20%
Mar 14 Fell Below 20 DMA Bearish 1.88%
Mar 14 180 Bearish Setup Bearish Swing Setup 1.88%
Mar 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.88%
Mar 14 Bollinger Band Squeeze Range Contraction 1.88%
Mar 13 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Older signals for CGIX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Cancer Genetics, Inc., an early-stage diagnostics company, focuses on the development and commercialization of proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. The company offers a range of services in various areas, including microarray based testing, a proprietary microarray test for the detection of chromosomal abnormalities observed in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma and Diffuse Large B-cell Lymphoma; molecular testing to analyze DNA and RNA to follow progression of disease and response to therapy at the genetic level; cytogenetics testing, a series of methods for analyzing human chromosomes to identify malignancy; fish testing, an analysis of abnormalities at the chromosomal and gene levels; flow cytometry testing, an immuno pheno - type analysis of specific markers inside cells; histology testing, a microscopic examination of stained tissue sections; cytology testing, a non-gynecological fluid preparation for microscopic evaluations by a pathologist; and IHC testing, an analysis of the distribution of tumor antigens in specific cell and tissue types. It offers DNA-based cancer diagnostics and services medical institutions. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also provides a range of non-proprietary oncology-focused tests and laboratory services that offer critical genomic information to healthcare professionals, as well as biopharma and biotech. The company was founded in 1999 and is headquartered in Rutherford, New Jersey.
Cancer Biology Disease Treatment Of Cancer Cancers Molecular Biology Tumor Lymphoma Healthcare Professionals Chronic Lymphocytic Leukemia Laboratory Services Anatomical Pathology Human Papillomavirus Infection Cytogenetics Dna Chip Fluorescence In Situ Hybridization
Is CGIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.05
52 Week Low 0.2
Average Volume 2,470,569
200-Day Moving Average 0.6676
50-Day Moving Average 0.2787
20-Day Moving Average 0.258
10-Day Moving Average 0.2576
Average True Range 0.0222
ADX 12.36
+DI 17.3157
-DI 13.1638
Chandelier Exit (Long, 3 ATRs ) 0.2134
Chandelier Exit (Short, 3 ATRs ) 0.2966
Upper Bollinger Band 0.2743
Lower Bollinger Band 0.2417
Percent B (%b) 0.56
BandWidth 12.635659
MACD Line -0.0048
MACD Signal Line -0.0062
MACD Histogram 0.0014
Fundamentals Value
Market Cap 5.15 Million
Num Shares 19.8 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -0.25
Price-to-Sales 1.94
Price-to-Book 2.87
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.29
Resistance 3 (R3) 0.29 0.28 0.28
Resistance 2 (R2) 0.28 0.27 0.28 0.28
Resistance 1 (R1) 0.27 0.27 0.27 0.27 0.28
Pivot Point 0.26 0.26 0.26 0.26 0.26
Support 1 (S1) 0.25 0.25 0.25 0.25 0.24
Support 2 (S2) 0.24 0.25 0.24 0.24
Support 3 (S3) 0.23 0.24 0.24
Support 4 (S4) 0.23